Single cell derived mRNA signals across human kidney tumors.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 06 2021
Historique:
received: 06 11 2020
accepted: 25 05 2021
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 20 7 2021
Statut: epublish

Résumé

Tumor cells may share some patterns of gene expression with their cell of origin, providing clues into the differentiation state and origin of cancer. Here, we study the differentiation state and cellular origin of 1300 childhood and adult kidney tumors. Using single cell mRNA reference maps of normal tissues, we quantify reference "cellular signals" in each tumor. Quantifying global differentiation, we find that childhood tumors exhibit fetal cellular signals, replacing the presumption of "fetalness" with a quantitative measure of immaturity. By contrast, in adult cancers our assessment refutes the suggestion of dedifferentiation towards a fetal state in most cases. We find an intimate connection between developmental mesenchymal populations and childhood renal tumors. We demonstrate the diagnostic potential of our approach with a case study of a cryptic renal tumor. Our findings provide a cellular definition of human renal tumors through an approach that is broadly applicable to human cancer.

Identifiants

pubmed: 34162837
doi: 10.1038/s41467-021-23949-5
pii: 10.1038/s41467-021-23949-5
pmc: PMC8222373
doi:

Substances chimiques

RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3896

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211276/Z/18/Z
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C9685/A25117
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209328/Z/17/Z
Pays : United Kingdom

Références

N Engl J Med. 2009 Apr 23;360(17):1787; author reply 1787-8
pubmed: 19387020
Bioinformatics. 2017 Dec 15;33(24):4033-4040
pubmed: 27592709
Nat Commun. 2020 Mar 11;11(1):1310
pubmed: 32161258
Cell Syst. 2016 Oct 26;3(4):346-360.e4
pubmed: 27667365
Cancer Cell. 2016 Mar 14;29(3):394-406
pubmed: 26977886
Cancer Cell. 2014 Sep 8;26(3):319-330
pubmed: 25155756
Nat Commun. 2021 Mar 3;12(1):1407
pubmed: 33658498
Pathology. 2008 Feb;40(2):217-27
pubmed: 18203043
PLoS Biol. 2019 Feb 21;17(2):e3000152
pubmed: 30789893
Development. 2018 Aug 30;145(16):
pubmed: 30166318
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Cell Rep. 2019 Feb 5;26(6):1627-1640.e7
pubmed: 30726743
Science. 2018 Aug 10;361(6402):594-599
pubmed: 30093597
Nat Commun. 2019 Jun 27;10(1):2832
pubmed: 31249312
Nat Commun. 2018 Jun 18;9(1):2378
pubmed: 29915264
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Curr Protoc Bioinformatics. 2016 Dec 8;56:15.10.1-15.10.18
pubmed: 27930805
Science. 2019 Dec 6;366(6470):1247-1251
pubmed: 31806814
Elife. 2018 Jul 11;7:
pubmed: 29993362
Nature. 2020 May;581(7808):303-309
pubmed: 32214235
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5
pubmed: 20837533
J Clin Oncol. 2015 Sep 20;33(27):2999-3007
pubmed: 26304882
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Nature. 2019 Feb;566(7745):490-495
pubmed: 30787436
Cell Rep. 2017 Aug 8;20(6):1476-1489
pubmed: 28793269
Gigascience. 2020 Dec 26;9(12):
pubmed: 33367645
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10595-9
pubmed: 8855223
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Dev Cell. 2008 Nov;15(5):781-91
pubmed: 19000842
Nature. 2010 Apr 15;464(7291):993-8
pubmed: 20393554
Cell Rep. 2018 Apr 3;23(1):313-326.e5
pubmed: 29617669
Nat Commun. 2019 Jan 22;10(1):380
pubmed: 30670690
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
Cell Syst. 2019 Apr 24;8(4):281-291.e9
pubmed: 30954476
Science. 2019 Sep 27;365(6460):1461-1466
pubmed: 31604275
Eur Urol. 2012 Dec;62(6):1013-9
pubmed: 22771265
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
Development. 2018 Feb 8;145(3):
pubmed: 29439135
Elife. 2016 Aug 24;5:
pubmed: 27557446
Cell Rep. 2018 Sep 25;24(13):3554-3567.e3
pubmed: 30257215
Nat Immunol. 2019 Jul;20(7):902-914
pubmed: 31209404
Methods Mol Biol. 2020;2148:229-244
pubmed: 32394386
Nat Biotechnol. 2017 Apr 11;35(4):319-321
pubmed: 28398307
Sci Adv. 2021 Feb 5;7(6):
pubmed: 33547074
PLoS One. 2011;6(10):e25240
pubmed: 22039408
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601

Auteurs

Matthew D Young (MD)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. my4@sanger.ac.uk.

Thomas J Mitchell (TJ)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Surgery, University of Cambridge, Cambridge, UK.

Lars Custers (L)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Thanasis Margaritis (T)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Francisco Morales-Rodriguez (F)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Kwasi Kwakwa (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Eleonora Khabirova (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Gerda Kildisiute (G)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Thomas R W Oliver (TRW)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Ronald R de Krijger (RR)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

Marry M van den Heuvel-Eibrink (MM)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Federico Comitani (F)

Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.

Alice Piapi (A)

UCL Great Ormond Street Hospital Institute of Child Health, London, UK.

Eva Bugallo-Blanco (E)

UCL Great Ormond Street Hospital Institute of Child Health, London, UK.

Christine Thevanesan (C)

UCL Great Ormond Street Hospital Institute of Child Health, London, UK.

Christina Burke (C)

UCL Great Ormond Street Hospital Institute of Child Health, London, UK.

Elena Prigmore (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Kirsty Ambridge (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Kenny Roberts (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Felipe A Vieira Braga (FAV)

Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Tim H H Coorens (THH)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Ignacio Del Valle (I)

UCL Great Ormond Street Hospital Institute of Child Health, London, UK.

Anna Wilbrey-Clark (A)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Lira Mamanova (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Grant D Stewart (GD)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Surgery, University of Cambridge, Cambridge, UK.

Vincent J Gnanapragasam (VJ)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Surgery, University of Cambridge, Cambridge, UK.
Cambridge Urology Translational Research and Clinical Trials office, Cambridge Biomedical Campus Cambridge CB2 0QQ University of Cambridge, Cambridge, UK.

Dyanne Rampling (D)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Neil Sebire (N)

NIHR Great Ormond Street Hospital BRC and Institute of Child Health, London, UK.

Nicholas Coleman (N)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Pathology, University of Cambridge, Cambridge, UK.

Liz Hook (L)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Pathology, University of Cambridge, Cambridge, UK.

Anne Warren (A)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Muzlifah Haniffa (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Intitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

Marcel Kool (M)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Hopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Division of Pediatric Neurooncology, Heidelberg, Germany.

Stefan M Pfister (SM)

Hopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Division of Pediatric Neurooncology, Heidelberg, Germany.
Heidelberg University Hospital, Department of Pediatric Hematology and Oncology, Heidelberg, Germany.

John C Achermann (JC)

UCL Great Ormond Street Hospital Institute of Child Health, London, UK.

Xiaoling He (X)

MRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK.

Roger A Barker (RA)

MRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK.

Adam Shlien (A)

Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.

Omer A Bayraktar (OA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Sarah A Teichmann (SA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Cavendish Laboratory, University of Cambridge, Cambridge, UK.

Frank C Holstege (FC)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Kerstin B Meyer (KB)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Jarno Drost (J)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.drost@prinsesmaximacentrum.nl.
Oncode Institute, Utrecht, The Netherlands. j.drost@prinsesmaximacentrum.nl.

Karin Straathof (K)

UCL Great Ormond Street Hospital Institute of Child Health, London, UK. k.straathof@ucl.ac.uk.
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. k.straathof@ucl.ac.uk.

Sam Behjati (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. sb31@sanger.ac.uk.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. sb31@sanger.ac.uk.
Department of Paediatrics, University of Cambridge, Cambridge, UK. sb31@sanger.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH